Stewart Dolin, a leader of Reed Smith's corporate department, committed suicide in 2010. His widow seeks $12 million for his death, alleging it was the result of an antidepressant whose suicidal side effects were covered up by GlaxoSmithKline. The pharmaceutical giant claims that Dolin's death was the result of an unpleasant work environment.
March 19, 2017 at 10:24 AM
1 minute read
Stewart Dolin, a 57-year-old former co-chair of Reed Smith’s corporate and securities practice, left the office nearly seven years ago and entered a Blue Line station for the Chicago Transit Authority. He then hurtled himself in front of a northbound “L” train.
Dolin’s death on July 15, 2010, was quickly ruled a suicide. But civil litigation grinds slowly, and now a federal jury in Chicago is being asked to rule on what led to Dolin’s demise.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
